Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.
Blood
; 138(4): 293-298, 2021 07 29.
Article
in English
| MEDLINE | ID: covidwho-1331924
ABSTRACT
The development of vaccines to fight COVID-19 has been a remarkable medical achievement. However, this global immunization effort has been complicated by a rare vaccine-related outcome characterized by thrombocytopenia and thrombosis in association with platelet-activating anti-platelet factor 4 antibodies. In this Spotlight, we will discuss the recently described complication of vaccine-induced immune thrombotic thrombocytopenia (VITT) occurring in response to certain COVID-19 vaccines. Although information about this clinical condition is rapidly evolving, we will summarize our current understanding of VITT.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Purpura, Thrombocytopenic, Idiopathic
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Blood
Year:
2021
Document Type:
Article
Affiliation country:
Blood.2021012152
Similar
MEDLINE
...
LILACS
LIS